-
Mashup Score: 1
Dr Renata Walewska moderates a case-based panel discussion on the management of adverse events with BTK inhibitors, including off-target effects of clinical concern. Independently created content, funded by BeiGene UK Ltd. Thank you to Beigene for providing sponsorship that made this project possible.
Source: thelimbic.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2ESMO 2023 – Skin cancer highlights through an Australian lens - 1 year(s) ago
Join online as a panel of experts presents their selection of skin cancer highlights from the ESMO 2023 Annual Meeting and discusses the impacts for patient care in Australia. Hosted by Professor Georgina Long AO Co-Medical Director of Melanoma Institute Australia (MIA), The University of Sydney. PRESENTING PANEL Associate Professor Sydney Ch’ng. Associate Professor of […]
Source: thelimbic.comCategories: General Medicine News, Oncologists2Tweet-
RT @thelimbiconc: REGISTER: https://t.co/u7pJKTv0o3 Our expert panel hosted by @ProfGLongMIA will deep dive into key Skin cancer updates fr…
-
-
Mashup Score: 1WEBINAR: Update and Debate in Myeloma - 1 year(s) ago
Join the limbic for an update on the key developments in clinical practice for myeloma in the UK over the last 12 months, along with a debate on whether CAR T-cell therapy will be usurped by bispecific therapy in the treatment of myeloma. Hosted by Prof. Graham Jackson. Consultant Haematologist at Newcastle Hospitals Trust, Newcastle upon Tyne […]
Source: thelimbic.comCategories: General Medicine News, Hem/OncsTweet-
RT @thelimbichaemUK: REGISTER: https://t.co/9DiIy5t4cL Join us for a discussion on the key developments in myeloma in the UK & whether CAR…
-
-
Mashup Score: 3
Supportive care in haemato-oncology In this four-part educational series on supportive care in haemato-oncology, our team of expert clinicians will guide you through what supportive care means in blood cancers, managing infection, dealing with treatment toxicities, and psychosocial support and palliative care. We will discuss whether clinicians and patients are always on the same page […]
Source: thelimbic.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @thelimbichaemUK: LISTEN: https://t.co/o46bNX0maY In this episode, @profBigG and @profghjackson discuss managing toxicities associated w…
-
-
Mashup Score: 1VIDEO: Professor Srihari Naidu insights from the VALOR-HCM study - 1 year(s) ago
In the VALOR-HCM trial, mavacamten reduced the need for septal reduction therapy in patients with obstructive hypertrophic cardiomyopathy. Speaking at the recent CSANZ 2023 meeting in Adelaide, Professor Srihari Naidu of Westchester Medical Centre, New York, explained the real world impact of the benefits of the selective allosteric and reversible cardiac myosin inhibitor for patients […]
Source: thelimbic.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @thelimbiccardio: WATCH: https://t.co/zviHwLoOLW Prof @SrihariNaiduMD explains insights from the VALOR-HCM study - discussing the benefi…
-
-
Mashup Score: 1Sex differences in HFpEF: ‘We need to do better’ - 1 year(s) ago
Women make up almost two-thirds of HFpEF cases and have more potent risk factors than men, but assessment and modification of cardiovascular risk factors in women remain poor, a leading cardiologist says. Presenting at CSANZ 2023 in Adelaide earlier this month, Associate Professor Clare Arnott said differences in heart failure between the sexes ranged from […]
Source: thelimbic.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @drsonyaburgess: Sex differences in HFpEF: ‘We need to do better’: https://t.co/2U5lN14Ylr.... more important messages about the importa…
-
-
Mashup Score: 4Sex differences in HFpEF: ‘We need to do better’ - 1 year(s) ago
Women make up almost two-thirds of HFpEF cases and have more potent risk factors than men, but assessment and modification of cardiovascular risk factors in women remain poor, a leading cardiologist says. Presenting at CSANZ 2023 in Adelaide earlier this month, Associate Professor Clare Arnott said differences in heart failure between the sexes ranged from […]
Source: thelimbic.comCategories: Cardiologists1, Latest HeadlinesTweet-
Sex differences in HFpEF: ‘We need to do better’: https://t.co/2U5lN14Ylr.... more important messages about the importance of gathering data disaggregated by sex and screening and treating CV risk factor in women
-
-
Mashup Score: 0A preview: what’s on in the west at the MOGA 2023 ASM - 1 year(s) ago
Convenors of MOGA’s 2023 Annual Scientific Meeting have considered both their geographic location in WA and the state of medical oncology clinical practice and research in their meeting theme “Frontiers in Cancer Care”. Dr Chandra Diwakarla and Associate Professor Tim Clay have pulled together a full and varied 3-day program of workshops, education and oral […]
Source: thelimbic.comCategories: Latest Headlines, Oncologists2Tweet-
Really looking forward to this @oncologyknitwit and @drtclay! Thanks for the @mayhemtomi invitation/mention. A preview: what’s on in the west at the MOGA 2023 ASM: https://t.co/UAxEAa2KDT
-
-
Mashup Score: 1Delaying diabetic CKD progression – the role of finerenone - 1 year(s) ago
Join online as an expert panel discusses a different approach to the challenge of CKD in diabetes. Featuring updates and commentary on key trial data, guidance on the use of finerenone in practice and discussion of its place in combination treatment and standard of care in Australia. Hosted by Professor Jonathan Shaw Deputy Director (Clinical […]
Source: thelimbic.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @thelimbicendo: SIGN UP: https://t.co/mms39Lua8f Following Finerenone's PBS listing, our experts discuss how it fits in the current trea…
-
-
Mashup Score: 0Interosseous tendon inflammation a precursor to RA: study - 1 year(s) ago
Inflammation around the hand interosseous tendons in patients with arthralgia signals a higher risk of developing rheumatoid arthritis, in both those with ACPA-positive and ACPA-negative disease, researchers have reported. The finding stems from a trial in the Netherlands involving 667 patients with clinical suspect arthralgia (mean age 44 years, 76% women) and 193 symptom-free controls […]
Source: thelimbic.comCategories: Latest Headlines, RheumatologyTweet-
Interosseous tendon inflammation a precursor to RA: study: https://t.co/JmmdAnwJ4H
-
RT @thelimbichaemUK: WATCH: https://t.co/Hb2v7pFive The recent MHRA approval of the second-generation BTK inhibitor zanubrutinib for patien…